Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SRP19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TSC22D2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ANGEL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC286359 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
BARD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP3R1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSRNP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO45 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTNNA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLCN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100630923 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP4R3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HCCS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VAMP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTF3L4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on